Abstracts tagged "Electronic Health Record"

Abstract Number: 334 • 2018 ACR/ARHP Annual Meeting
Use of Handheld Device to Enhance Patient Reported Outcome Measure Data Collection in an Academic Rheumatology Practice
Vivek Nagaraja¹, Vladimir Ognenovski² and Dinesh Khanna¹, ¹Division of Rheumatology, Department of Internal Medicine, University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, MI, ²Department of Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI
Background/Purpose: Patient-reported outcome measures (PROMs) are accepted modalities of gathering patient self-report of their health status in the realms of physical, mental and social well-being.…
Abstract Number: 2423 • 2018 ACR/ARHP Annual Meeting
Births to Women with Systemic Lupus Erythematosus Can be Identified Accurately in the Electronic Health Record
Ashley Blaske¹, Amanda M. Eudy², Jim C. Oates³, Megan E. B. Clowse² and April Barnado⁴, ¹Medicine and Pediatrics, Vanderbilt University Medical Center, Nashville, TN, ²Division of Rheumatology, Department of Medicine, Duke University Medical Center, Durham, NC, ³Division of Rheumatology & Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC, ⁴Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN
Background/Purpose: Studying births in women with systemic lupus erythematosus (SLE) is difficult given its rarity and the challenges of randomized trials. While the electronic health…
Abstract Number: 337 • 2018 ACR/ARHP Annual Meeting
Does a Best Practice Alert Improve RA Patient Referral to Preventative Cardiology?
Savanna Smoker¹, Ellen Romich², Amy Nowacki³ and M. Elaine Husni⁴, ¹Case Western Reserve University, Cleveland, OH, ²Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, ³Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, ⁴Rheumatology, Cleveland Clinic, Cleveland, OH
Background/Purpose: RA patients are at about 50% increased risk of cardiovascular disease (CVD)1. Despite this risk, numerous studies show inadequate cardiovascular risk assessment of these…
Abstract Number: 2802 • 2018 ACR/ARHP Annual Meeting
Risk of Ischemic Stroke in Veterans with Systemic Sclerosis: A Nationwide Cohort Study
David Ying^1,2, Milena Gianfrancesco¹, Laura Trupin¹, Jinoos Yazdany¹, Eric Greidinger^3,4 and Gabriela Schmajuk^2,5, ¹Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ²San Francisco VA Medical Center, San Francisco, CA, ³Medicine/Rheumatology, University of Miami Miller School of Medicine, Miami, FL, ⁴Miami VA Medical Center, Miami, FL, ⁵Medicine/Rheumatology, University of California - San Francisco, San Francisco, CA
Background/Purpose: Previously thought to involve primarily the microvasculature, systemic sclerosis (SSc) has been increasingly linked to macrovascular disease. Cardiovascular and cerebrovascular disease are responsible for…
Abstract Number: 338 • 2018 ACR/ARHP Annual Meeting
Implementation of an Automated Phrase to Increase Awareness of Cardiovascular Risk in Rheumatoid Arthritis Patients in an Urban Fellows Rheumatology Clinic
Leslie Anne Cassidy¹, Jennifer Brandt¹, Alison Gizinski², Arezou Khosroshahi¹, Gaobin Bao¹ and S. Sam Lim³, ¹Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA, ²Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia, ³Emory University School of Medicine, Atlanta, GA
Background/Purpose: Rheumatoid arthritis (RA) is a significant and well-established risk factor for atherosclerotic cardiovascular disease (ASCVD). Cardiovascular risk stratification is often left to the primary…
Abstract Number: 2859 • 2018 ACR/ARHP Annual Meeting
Do Preventive Cardiology Consults Versus Usual Care Improve Cardiovascular Risk Factor Assessment and Management in Patients with Rheumatoid Arthritis?
Ellen Romich¹, Haitham Ahmed², Amy Nowacki³ and M. Elaine Husni⁴, ¹Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, ²Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, ³Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, ⁴Rheumatology, Cleveland Clinic, Cleveland, OH
Background/Purpose: Rheumatoid arthritis (RA) patients have around 50% increased risk of cardiovascular disease (CVD). Both traditional and RA-specific cardiovascular (CV) risk factors contribute to the…
Abstract Number: 448 • 2018 ACR/ARHP Annual Meeting
Tizanidine, a Frequently Used Muscle Relaxant, Is Associated with Severe Hypotension: Role of Cytochrome P450 1A2 Inhibition in Routine Clinical Practice
Sandip Chaugai¹, Alyson Dickson², Megan Shuey², QiPing Feng², Katherine Barker², James Luther², C. Michael Stein³ and Cecilia P. Chung³, ¹Medicine, Vanderbilt University Medical Center, Nashville, TN, ²Vanderbilt University Medical Center, Nashville, TN, ³Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
Background/Purpose: Tizanidine, a muscle relaxant widely used for musculoskeletal pain, can lower blood pressure and is metabolized by the cytochrome P450 1A2 (CYP1A2). As a…
Abstract Number: 2962 • 2018 ACR/ARHP Annual Meeting
Diagnostic Accuracy of Gout in Electronic Health Records and the Role of Rheumatology Electronic Consults
Juliana Chang¹ and Maida Wong², ¹Internal Medicine, University of California, Irvine, School of Medicine, Orange, CA, ²Rheumatology, Tibor Rubin VA Medical Center, Orange, CA
Background/Purpose: Gout is the most prevalent inflammatory arthritis globally. Despite treatment advances, it still has a significant effect on quality of life and healthcare costs.…
Abstract Number: 466 • 2018 ACR/ARHP Annual Meeting
Improving Pneumococcal Vaccination Rates in Childhood-Onset SLE Patients at a Large Tertiary Care Center: The Path to Creating a More Sustainable Model of Vaccination with the Help of EMR
Saimun Singla and Marietta M. De Guzman, Pediatric Immunology, Allergy and Rheumatology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX
Background/Purpose: Streptococcus pneumonia is a leading cause of illness in children worldwide and can lead to death in those with an immunosuppressed status. Given the…
Abstract Number: 1164 • 2018 ACR/ARHP Annual Meeting
Canadians’ Views about Using Big Data in Health Research from a National Online Survey: A Partnership of Patient-Consumers and Researchers
Natalie McCormick¹, Clayon Hamilton^1,2, Cheryl L. Koehn³, Kelly English⁴, Allan Stordy⁵ and Linda Li^1,6, ¹Arthritis Research Canada, Richmond, BC, Canada, ²Physical Therapy, The University of British Columbia, Vancouver, BC, Canada, ³Arthritis Consumer Experts, Vancouver, BC, Canada, ⁴Arthritis Patient Advisory Board, Arthritis Research Canada, Richmond, BC, Canada, ⁵Canadian Skin Patient Alliance, Calgary, AB, Canada, ⁶Department of Physical Therapy, The University of British Columbia, Vancouver, BC, Canada
Background/Purpose: Findings from health research using “big data” (large sets of routinely-collected healthcare data) have benefitted individual arthritis patients and society as-a-whole. However, growing…
Abstract Number: 1242 • 2018 ACR/ARHP Annual Meeting
Rheumatologists Participating in the RISE Registry Succeeded in the First Year of the Merit-Based Incentive Payment System (MIPS)
Tracy Johansson¹, Ryan Larosa², Rachel Myslinski³, Norlita Brown¹, Lindsay Lewis¹ and Jinoos Yazdany⁴, ¹Practice, Advocacy & Quality, American College of Rheumatology, Atlanta, GA, ²American College of Rheumatology, Atlanta, GA, ³Practice, Advocacy, & Quality, American College of Rheumatology, Atlanta, GA, ⁴University of California, San Francisco, San Francisco, CA
Background/Purpose: Under the Medicare Access and CHIP Reauthorization Act (MACRA), rheumatologists face financial repercussions through the Merit-Based Incentive Payment System (MIPS) based on performance on…
Abstract Number: 1408 • 2018 ACR/ARHP Annual Meeting
Using Patient Reported Outcomes at Point of Care in Immune Mediated Diseases: Minimal Clinically Important Differences
M. Elaine Husni¹, Chad Deal², Leonard H. Calabrese³, Greg Strnad⁴, James Bena⁵ and Abby Abelson⁶, ¹Orthopedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH, ²Cleveland Clinic, Shaker Heights, OH, ³Rheumatology, Cleveland Clinic, Cleveland, OH, ⁴Cleveland Clinic, Cleveland, OH, ⁵Quantitative Health Science, QHS Cleveland Clinic, Cleveland, OH, ⁶Department of Rheumatologic & Immunologic Disease, Cleveland Clinic, Cleveland, OH
Background/Purpose: Patient reported measures of global health and disease activity are increasingly used in routine care; however, detecting meaningful change in clinical status (responsiveness) is difficult…
Abstract Number: 1686 • 2018 ACR/ARHP Annual Meeting
Rule-Based Algorithm Using Systemic Lupus International Collaborating Clinics (SLICC) Classification Criteria to Identify Patients with Systemic Lupus Erythematosus (SLE) from Electronic Health Record (EHR) Data
Anika S. Ghosh¹, Theresa L. Walunas², Kathryn L. Jackson¹, Ahn H. Chun³, Daniel L. Erickson³, Karen Mancera-Cuevas⁴, Abel N. Kho³ and Rosalind Ramsey-Goldman⁵, ¹Center for Health Information Partnerships, Northwestern University, Chicago, IL, ²Department of Medicine, Division of General Internal Medicine and Geriatrics, Northwestern University, Chicago, IL, ³Northwestern University, Chicago, IL, ⁴Rheumatology, Northwestern University, Chicago, IL, ⁵FSM, Northwestern University, Chicago, IL
Background/Purpose: Systemic Lupus Erythematosus (SLE) is an autoimmune disease that can affect many parts of the body including skin, lungs, brain, heart, kidneys, joints, and…
Abstract Number: 1692 • 2018 ACR/ARHP Annual Meeting
Using ICD-10-CM Codes to Identify Patients with Systemic Lupus Erythematosus in the Electronic Health Record
April Barnado¹, Robert Carroll², Joshua C. Denny² and Leslie Crofford¹, ¹Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN, ²Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN
Background/Purpose: The electronic health record (EHR) serves as a powerful tool to enable researchers to collect a large cohort of patients across the healthcare system. …
Abstract Number: 1891 • 2018 ACR/ARHP Annual Meeting
Patterns of Biosimilar Use in the Rheumatology Informatics System for Effectiveness (RISE) Registry
Nick Bansback¹, Jeffrey R. Curtis², Jie Huang³, Lindsay Lewis⁴, Tracy Johansson⁴, Kaleb Michaud⁵ and Katherine P. Liao³, ¹St Paul's Hospital, Centre for Health Evaluation and Outcomes Sciences, Vancouver, BC, Canada, ²University of Alabama at Birmingham, Birmingham, AL, ³Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ⁴Practice, Advocacy & Quality, American College of Rheumatology, Atlanta, GA, ⁵Rheumatology, University of Nebraska Medical Center, Omaha, NE
Background/Purpose: In the U.S., the first biosimilar tumor necrosis inhibitor (TNFi) was approved in 2016. To date, only biosimilars for infliximab are available in the…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].